Quantcast

Court Approves Yaz Class Action as Settlements Continue, DrugRisks Reports

May 20, 2013

http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today.

Orlando, FL (PRWEB) May 20, 2013

The birth control resource center at DrugRisks.com is announcing new information on the site for women using the oral contraceptives Yaz and Yasmin. A court in Canada has certified a class action for patients alleging blood clot injuries, as Bayer continues to pay settlements to victims in the United States*.

The goal of DrugRisks is to improve the safety of patients taking popular prescription drugs like Yaz and Yasmin, by offering the latest warnings, recalls, studies and legal news. Visitors can discover if others are experiencing similar side effects and decide if they need legal advice.

The resource center has added warnings from British Medical Journal** and FDA*** that birth control pills containing drospirenone, like Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

With the number of patients in the U.S. who filed a Yaz lawsuit alleging blood clot injuries, DrugRisks also learned that cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

Bayer´s latest annual financial report shows the company has spent nearly $1 billion to settle around 4,800 claims alleging Yaz blood clots, and will continue to evaluate new claims for settlement on a case-by-case basis****.

Now, DrugRisks has added information that the Honourable Justice Crane of the Ontario Superior Court of Justice certified a Yaz and Yasmin class action on April 15, 2013*.

Lawyers are still helping patients affected in the United States file a claim. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisks Center or speak with a lawyer about their legal options.

DrugRisks cautions that patients should seek a lawyer with experience in this type of litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to Yaz or Yasmin, or to speak with a lawyer.

*Global News, 4/18/13; globalnews.ca/news/492236/ontario-judge-gives-green-light-to-yasmin-yaz-class-action-lawsuit/

**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398

***FDA, 10/27/11, fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf

****Bayer 2/28/13; annualreport2012.bayer.com/en/legal-risks.aspx

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebdrugrisks-lawsuit/yaz-center/prweb10750270.htm


Source: prweb



comments powered by Disqus